Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Leveraging genetics to help inform drug target discovery

General Research

Researchers from the University of Oxford, together with colleagues across Europe as part of the ULTRA-DD Consortium (Unrestricted Leveraging of Targets for Research Advancement and Drug Discovery) have established a novel approach to maximise the informativeness of genetic evidence for drug target prioritisation.

In a paper published today in Nature Genetics, Professor Julian Knight at the Wellcome Centre for Human Genetics and colleagues from the ULTRA-DD Consortium shows how genetics and knowledge of networks can prioritise drug targets for immune-mediated diseases. 

The Priority Index or ‘Pi’ pipeline was developed by the study first-author Dr Hai Fang to be open-source and customisable, promoting collaborative efforts to accelerate early-stage drug development. This ethos was central to the ULTRA-DD Consortium, which included academic and pharma partners through an Innovative Medicines Initiative. A web interface allows users to visualise gene priority ratings, underlying data and analysis.

Read more (Wellcome Centre for Human Genetics website)

Similar stories

NHS garden in full bloom at RHS Chelsea Flower Show

The sun was shining for the RHS Chelsea Flower show press day earlier this week. One garden in particular bloomed particularly brightly, with the 'Finding Our Way: An NHS Tribute Garden' getting plenty of attention.

University of Oxford launches Podium Analytics Institute for Youth Sports Medicine and Technology

Oxford University has been selected as the home of the new Podium Analytics Institute for Youth Sports Medicine and Technology. This will be the world’s first academic Institute focused on young athletes’ safety and lifelong health and will combine Oxford’s longstanding tradition in sports and education with the very best of science, medicine, and technology.

QCovid highly commended for ‘best use of technology in Patient Safety’ at the 2021 HSJ Patient Safety Awards

Professor Julia Hippisley-Cox and her team in Nuffield Department of Primary Care Health Sciences have been Highly Commended in the ‘Best use of technology in Patient Safety’ category for the QCovid risk calculator at this year’s Health Service Journal Patient Safety Awards.

New guidelines to improve reporting standards of studies that investigate causal mechanisms

Researchers in the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have developed a new set of guidelines for reporting mediation analyses in health research.

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

COVID winter plan: UK blueprint doesn’t go far enough – here’s a health expert’s alternative